½ÃÀ庸°í¼­
»óǰÄÚµå
1796138

¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼® : ¼­ºñ½ºº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ¿¹Ãø(2025-2032³â)

Central Lab Market Size, Share, and Growth Analysis, By Services (Biomarker Services, Genetic Services), By End-User (Pharmaceutical Companies, Biotechnology Companies), By Region - Industry Forecast 2025-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 30¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â 31¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 52¾ï 4,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, ¿¹Ãø ±â°£(2025-2032³â)ÀÇ CAGRÀº 6.4%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ¼¾Æ®·² ·¦ ½ÃÀåÀº È¿À²ÀûÀÎ ÀÓ»ó½ÃÇè ÇÁ·Î¼¼½º¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, º¹ÀâÇØÁö´Â ÀǾàǰ ½ÃÀå °³¹ß, ºñ¿ë È¿À²ÀûÀÎ Áß¾Ó ÁýÁᫎ Áø´Ü ¼­ºñ½º¿¡ ´ëÇÑ ´ÏÁî µîÀ» ¹è°æÀ¸·Î Å« ¼ºÀåÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. ½ÇÇè½Ç ÀÚµ¿È­ Çõ½Å, Á¦¾à R&D¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, CRO ¹× »ý¸í°øÇÐ ±â¾÷ÀÇ ÅëÇÕ ½ÇÇè½Ç ¼­ºñ½º ÀÌ¿ë Áõ°¡°¡ ÀÌ·¯ÇÑ Ãß¼¼¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. AI, ¸Ó½Å·¯´×, Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛ µîÀÇ ±â¼úÀº ½ÇÇè½Ç ¾÷¹«¸¦ °­È­Çϰí ÀÓ»ó½ÃÇèÀÇ °á°ú¸¦ °¡¼ÓÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á¿Í ¹ÙÀÌ¿À¸¶Ä¿ °Ë»çÀÇ ±ÞÁõÀº Á¤È®¼º°ú Àû½Ã¼ºÀ» À§ÇØ Áß¾Ó ÁýÁᫎ ½ÇÇè½Ç ¸ðµ¨¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. µðÁöÅÐ ÅëÇÕ°ú µ¥ÀÌÅÍ Á¤È®µµ Çâ»óÀÌ ½ÃÀåÀÇ ÀáÀç·ÂÀ» ³ôÀÌ´Â ¹Ý¸é, ³ôÀº Ãʱâ ÅõÀÚ ºñ¿ë°ú µ¥ÀÌÅÍ º¸¾È ¹®Á¦ µîÀº ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ ÀϽÃÀûÀÎ Á¦¾àÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

¼­·Ð

  • Á¶»çÀÇ ¸ñÀû
  • Á¶»ç ¹üÀ§
  • Á¤ÀÇ

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷¿Í 1Â÷ µ¥ÀÌÅÍ ¹æ¹ý
  • ½ÃÀå ±Ô¸ð ¿¹Ãø
  • ½ÃÀåÀÇ ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

°³¿ä

  • ¼¼°è ½ÃÀå Àü¸Á
  • °ø±Þ°ú ¼ö¿ä µ¿Ç⠺м®
  • ºÎ¹®º° ±âȸ ºÐ¼®

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀΰú ±âȸ
    • ¾ïÁ¦¿äÀΰú °úÁ¦
  • PorterÀÇ »ê¾÷ ºÐ¼®

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ÁÖ¿ä ¼º°ø ¿äÀÎ
  • °æÀïÀÇ Á¤µµ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ½ÃÀå ¿¡ÄڽýºÅÛ
  • ½ÃÀåÀÇ ¸Å·Â Áö¼ö(2024³â)
  • PESTEL ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ¹ë·ùüÀÎ ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±â¼ú ºÐ¼®
  • »ç·Ê ¿¬±¸
  • °í°´ ±¸¸Å Çൿ ºÐ¼®

¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð : ¼­ºñ½ºº° & CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ¹ÙÀÌ¿À¸¶Ä¿ ¼­ºñ½º
  • À¯ÀüÀÚ ¼­ºñ½º
  • ¹Ì»ý¹°ÇÐ ¼­ºñ½º
  • Ư¼öÈ­ÇÐ ¼­ºñ½º
  • Á¶Á÷ÇÐ
  • Ç¥º» °ü¸®¿Í º¸°ü

¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð : °èÀ庰 & CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ÀÚµ¿ ºÐ¼®±â
  • Çö¹Ì°æ°Ë»ç
  • ºÐ±¤ ºÐ¼®
  • Å©·Î¸¶Åä±×·¡ÇÇ
  • Àü±â¿µµ¿

¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð : ±â¼úº° & CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR)
  • ¸é¿ªÁ¶Á÷È­ÇÐ
  • À¯¼¼Æ÷ºÐ¼®
  • Áú·®ºÐ¼®
  • Â÷¼¼´ë ½ÃÄö½Ì

¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð : ÃÖÁ¾»ç¿ëÀÚº° & CAGR(2025-2032)

  • ½ÃÀå °³¿ä
  • Á¦¾àȸ»ç
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú
  • Á¶»ç±â°ü

¼¾Æ®·² ·¦ ½ÃÀå ±Ô¸ð : Áö¿ªº° & CAGR(2025-2032)

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´ Áö¿ª
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« Áö¿ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï Á¤º¸

  • »óÀ§ 5»çÀÇ ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2024³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ÃÖ±Ù ½ÃÀå µ¿Çâ
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • ÁÖ¿ä ±â¾÷ÀÇ ±â¾÷ °³¿ä
    • ±â¾÷ÀÇ »ó¼¼
    • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
    • ±â¾÷ÀÇ ºÎ¹®º° Á¡À¯À² ºÐ¼®
    • ¸ÅÃâÀÇ Àü³â´ëºñ ºñ±³(2022-2024³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • ACM Global Laboratories
  • Eurofins Scientific
  • ICON plc
  • Labcorp
  • Thermo Fisher Scientific
  • Cerba Research
  • Medicover Integrated Clinical Services
  • Medspace
  • Bioscientia
  • Barc Lab
  • CIRION BioPharma Research

°á·Ð°ú Á¦¾È

KSA 25.08.29

Global Central Lab Market size was valued at USD 3.0 billion in 2023 and is poised to grow from USD 3.19 billion in 2024 to USD 5.24 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

The Global Central Lab market is experiencing significant growth driven by increasing demands for efficient clinical trial processes, the complexities of drug development, and a need for cost-effective centralized diagnostic services. Innovations in laboratory automation, rising investments in pharmaceutical research and development, and the heightened use of integrated lab services by CROs and biotech firms contribute to this trend. Technologies like AI, machine learning, and cloud-based systems are enhancing lab operations and expediting clinical study outcomes. Furthermore, the surge in personalized medicine and biomarker testing is fostering a reliance on centralized lab models for accuracy and timeliness. While digital integration and improved data accuracy bolster market potential, challenges such as high initial investments and data security issues may pose temporary constraints, especially in developing regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Central Lab market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Central Lab Market Segments Analysis

Global Central Lab Market is segmented by Services, End-User and region. Based on Services, the market is segmented into Biomarker Services, Genetic Services, Microbiology Services, Special Chemistry Services, Histology and Specimen Management & Storage. Based on End-User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Central Lab Market

The central lab market is experiencing significant growth driven by the increasing number of clinical trials, especially in areas such as oncology, rare diseases, and vaccines. Central labs offer consistent testing, standardized data management, and rapid reporting across various study locations, which are essential for enhancing trial efficiency and reliability. As multinational pharmaceutical companies expand their portfolios, there is a heightened demand for laboratories that can ensure regulatory compliance while also optimizing operational performance. This trend reflects the broader shift towards more complex and diverse research endeavors, further underscoring the importance of central labs in contemporary clinical development.

Restraints in the Global Central Lab Market

The Global Central Lab market faces significant constraints due to the substantial investment required for establishing and maintaining central lab facilities. This includes high expenditures for specialized equipment, advanced technology platforms, data management systems, and the recruitment of skilled personnel. These considerable capital and ongoing operational costs create barriers for smaller laboratories and emerging contract research organizations, ultimately restricting their potential for growth and market penetration. As a result, the financial burden associated with developing and continuing lab operations can hinder innovation and limit the overall expansion of the market.

Market Trends of the Global Central Lab Market

The Global Central Lab market is witnessing a notable trend driven by the increasing adoption of outsourcing among pharmaceutical and biotechnology firms. This shift allows these organizations to leverage enhanced scalability, extensive international trial coverage, and improved regulatory harmonization, which are critical for navigating the complexities of clinical trials. As companies seek to optimize resources and streamline operations, central lab services are becoming increasingly essential, offering specialized expertise and cutting-edge technology. This trend is anticipated to enhance operational efficiencies while also facilitating faster and more reliable data collection and analysis, ultimately contributing to the acceleration of drug development timelines and improved patient outcomes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Central Lab Market Size by Services & CAGR (2025-2032)

  • Market Overview
  • Biomarker Services
  • Genetic Services
  • Microbiology Services
  • Special Chemistry Services
  • Histology
  • Specimen Management & Storage

Global Central Lab Market Size by Instrumentation & CAGR (2025-2032)

  • Market Overview
  • Automated Analyzers
  • Microscopy
  • Spectrometry
  • Chromatography
  • Electrophoresis

Global Central Lab Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry
  • Flow Cytometry
  • Mass Spectrometry
  • Next Generation Sequencing

Global Central Lab Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academics
  • Research Institutes

Global Central Lab Market Size & CAGR (2025-2032)

  • North America (Services, Instrumentation, Technology, End-User)
    • US
    • Canada
  • Europe (Services, Instrumentation, Technology, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Services, Instrumentation, Technology, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Services, Instrumentation, Technology, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Services, Instrumentation, Technology, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • ACM Global Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labcorp
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerba Research
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicover Integrated Clinical Services
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medspace
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bioscientia
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Barc Lab
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CIRION BioPharma Research
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦